Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Tateno

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cancers|May 14, 2025
Targeting Autophagy for Pituitary TumorsEvan Yin, Motoyasu Satou, Toru Tateno
Endocrinology and Metabolism (Seoul, Korea)|August 30, 2024
Pituitary Neuroendocrine Tumors in Multiple Endocrine NeoplasiaSang Ouk Chin, Constance Chik, Toru Tateno
Cell Biology International|January 13, 2006
Role of C-terminus of Kir7.1 potassium channel in cell-surface expressionToru Tateno, Nobuhiro Nakamura, Yukio Hirata, et al.
Endocrinology and Metabolism (Seoul, Korea)|November 15, 2023
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine TumorsElizabeth Whyte, Masahiro Nezu, Constance Chik, et al.
Endocrinology|June 9, 2016
Role of mTOR Inhibitors in Growth Hormone-Producing Pituitary Adenomas Harboring Different FGFR4 GenotypesShahrzad Jalali, Eric Monsalves, Toru Tateno, et al.
Cells|September 26, 2025
The Pituitary Immune Environment and Immunotherapy: From Hypophysitis to Pituitary Neuroendocrine TumorsToru Tateno, Mariam Shahidi, Jian-Qiang Lu, et al.
Molecular and Cellular Endocrinology|January 12, 2010
Chromatin remodeling and histone modifications in pituitary tumorsToru Tateno, Xuegong Zhu, Sylvia L Asa, et al.
Endocrine-Related Cancer|April 7, 2016
NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cellsToru Tateno, Tae Nakano-Tateno, Shereen Ezzat, et al.
Peptides|August 8, 2006
Presence of immunoreactive salusin-alpha in human serum and urineKengo Sato, Takatoshi Koyama, Toru Tateno, et al.
Endocrine Journal|July 12, 2021
Emerging role of signal transducer and activator of transcription 3 (STAT3) in pituitary adenomasCyndy Liu, Tae Nakano-Tateno, Motoyasu Satou, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cancers|May 14, 2025
Targeting Autophagy for Pituitary TumorsEvan Yin, Motoyasu Satou, Toru Tateno
Endocrinology and Metabolism (Seoul, Korea)|August 30, 2024
Pituitary Neuroendocrine Tumors in Multiple Endocrine NeoplasiaSang Ouk Chin, Constance Chik, Toru Tateno
Cell Biology International|January 13, 2006
Role of C-terminus of Kir7.1 potassium channel in cell-surface expressionToru Tateno, Nobuhiro Nakamura, Yukio Hirata, et al.
Endocrinology and Metabolism (Seoul, Korea)|November 15, 2023
Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine TumorsElizabeth Whyte, Masahiro Nezu, Constance Chik, et al.
Endocrinology|June 9, 2016
Role of mTOR Inhibitors in Growth Hormone-Producing Pituitary Adenomas Harboring Different FGFR4 GenotypesShahrzad Jalali, Eric Monsalves, Toru Tateno, et al.
Cells|September 26, 2025
The Pituitary Immune Environment and Immunotherapy: From Hypophysitis to Pituitary Neuroendocrine TumorsToru Tateno, Mariam Shahidi, Jian-Qiang Lu, et al.
Molecular and Cellular Endocrinology|January 12, 2010
Chromatin remodeling and histone modifications in pituitary tumorsToru Tateno, Xuegong Zhu, Sylvia L Asa, et al.
Endocrine-Related Cancer|April 7, 2016
NG2 targets tumorigenic Rb inactivation in Pit1-lineage pituitary cellsToru Tateno, Tae Nakano-Tateno, Shereen Ezzat, et al.
Peptides|August 8, 2006
Presence of immunoreactive salusin-alpha in human serum and urineKengo Sato, Takatoshi Koyama, Toru Tateno, et al.
Endocrine Journal|July 12, 2021
Emerging role of signal transducer and activator of transcription 3 (STAT3) in pituitary adenomasCyndy Liu, Tae Nakano-Tateno, Motoyasu Satou, et al.
Pageof 4